Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dose-dependent, opioid-induced sleep disruption is partially mediated by motor activity but not by body temperature in C57BL/6J mice.

The Journal of pharmacology and experimental therapeutics·2025

Same author

Cell-Free DNA as a Surveillance Tool for Hepatocellular Carcinoma Patients after Liver Transplant.

Cancers·2023

Same author

Is the Omicron variant truly less virulent in solid organ transplant recipients?

Transplant infectious disease : an official journal of the Transplantation Society·2022

Same author

Buprenorphine differentially alters breathing among four congenic mouse lines as a function of dose, sex, and leptin status.

Respiratory physiology & neurobiology·2021

Same author

Opioids cause dissociated states of consciousness in C57BL/6J mice.

Journal of neurophysiology·2021

Same author

When is it safe to perform abdominal transplantation in patients with prior SARS-CoV-2 infection: A case series.

Clinical transplantation·2021

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

The hospitalized patient with abnormal liver function tests.

Christopher B O'Brien¹

¹Divisions of Liver and Gastrointestinal Transplantation, Center for Liver Diseases, University of Miami Miller School of Medicine, 1500 NW 12th Avenue, Suite #1101 Miami, FL 33136, USA. cobrien@med.miami.edu

Clinics in Liver Disease

|May 16, 2009

Summary

This summary is machine-generated.

Evaluating abnormal liver function tests (LFTs) in hospitalized patients requires a structured approach. This involves determining the cause, severity, and complications of liver dysfunction for timely medical intervention.

More Related Videos

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl₄) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Related Experiment Videos

Last Updated: Jun 23, 2026

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl₄) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Area of Science:

Hepatology
Internal Medicine
Clinical Diagnostics

Background:

Abnormal liver function tests (LFTs) in hospitalized patients demand urgent evaluation.
A systematic approach is crucial for accurate diagnosis and management.

Purpose of the Study:

To outline a structured, four-step process for evaluating abnormal LFTs in hospitalized patients.
To differentiate LFT abnormalities related to acute illness versus pre-existing conditions.

Main Methods:

Step 1: Differentiate LFTs related to current hospitalization versus preceding illness.
Step 2: Determine the etiology of underlying liver disease.
Step 3: Assess liver dysfunction severity, identifying acute liver failure (ALF) or decompensated chronic liver failure.
Step 4: Identify associated complications of acute or chronic liver failure.

Main Results:

The proposed four-step framework provides a clear pathway for clinical decision-making.
This systematic evaluation aids in timely diagnosis and appropriate management of liver dysfunction.

Conclusions:

A structured, four-step evaluation is essential for managing abnormal LFTs in hospitalized patients.
This approach facilitates the identification of liver disease etiology, severity, and complications, guiding patient care.